Peptides na Musamman don Binciken Sufuri na SLC

Menene Masu jigilar SLC kuma Me yasa Suke Maƙasudin Maƙasudi?

Masu jigilar SLC sune sunadarai masu ɗaukar nauyi waɗanda ke motsa ions, na gina jiki, neurotransmitters da kwayoyi a fadin membranes tantanin halitta, kuma mutane suna da 464 sanann membobin sun baje ko'ina 70 iyalai (Labarai-Likita, 2026-09-10). Su kuma batutuwan dakin gwaje-gwaje masu taurin kai, kuma dalilai na tsari ne maimakon tsari.

Wahalar tana farawa da gine-gine. Masu jigilar SLC su ne sunadarai na membrane na haɗin gwiwa da aka gina daga yawancin helices transmembrane, wanda ke sa su da wuyar bayyanawa, solubility, tsarkakewa da crystallize (PMC, 2025-09-02). Da yawa suna aiki ta hanyar sake zagayowar shiga, canzawa tsakanin fuskantar ciki, jahohin da suka fake da na waje, don haka gwaji guda yana ƙoƙarin ɗaukar kamanni ɗaya maimakon duka hoto. Matakan magana na asali sau da yawa ba su da yawa, wanda ke dagula tsarkakewa, antibody tsara da kuma tsarin aiki, kuma matsar da furotin zuwa maganin wanke-wanke na iya rikitar da tsarin da kuke ƙoƙarin yin nazari.

Ayyukan karantawa suna da ƙuntatawa. Yawancin SLCs ba su da sanannen tushe ko ƙaƙƙarfan tantancewar sakandare, kuma ma'aunin sufuri yana ruɗe da ƙayyadaddun ma'auni, electroneutrality, gidauniya, shugabanci da artefacts, tare da overlapping substrate promiscuity ƙara wani Layer na fassarar.

Sakamakon shine dangin da magani bai taɓa taɓawa ba. Magungunan da suka wanzu suna magana kaɗan kaɗan na babban iyali na SLC (Labarai-Likita, 2026-09-10), kuma daya 2026 yanki na ra'ayi ya kiyasta cewa na babban iyali ya wuce 400 mambobi, kusan kashi uku ba su da masaniyar ligand kwata-kwata (Binciken Clinical Vanguard, 2026-09-07). Wannan hadin, mai wuyar bayyanawa, wuya a riƙe a cikin jiha ɗaya, mai wuyar aunawa, shi ne ainihin dalilin da ya sa peptide reagent mai kyau ya sami matsayinsa a farkon aikin jigilar kaya..

Me yasa Peptides na Musamman don Binciken Jirgin SLC ya dace da Gano Farko

peptides na al'ada don binciken jigilar jigilar SLC sun dace da gano wuri da wuri saboda an ayyana su a jere, labelable da modifiable reagents da za a iya gina a kan hari inda antibodies, mahadi na kayan aiki da ilmin halitta tsarin sun tsaya cak. Tazarar kayan aiki-haɗe-haɗe shine mafi bayyanan shaida ga wannan dacewa. A 2024 binciken na mahadi kayan aikin SLC a Gaba a cikin Pharmacology tacewa 20,678 musamman kananan kwayoyin halitta a fadin 199 SLCs da, bayan amfani da ma'auni na kayan aiki, isa a 6,876 masu hanawa rufe kawai 51 masu sufuri. Haka binciken ya gano cewa 530 na 810 da hannu curated fili/SLC nau'i-nau'i ba su nan daga bayanan da aka gwada, da kuma cewa ga yawancin SLC da ke da alaƙa da cuta akwai ƙima yayin da ba a gano kayan aikin ba kwata-kwata.

Key Takeaway: Levers huɗu sun yanke shawarar ko peptide reagent yana aiki a aikin jigilar kaya: jerin da kuka zaɓa, alamar da kuka haɗa, gyare-gyaren kwanciyar hankali da kuke nema, da kuma shaidar nazari da za ku iya nunawa don kuri'a.

Tabbatar da Cascade: Tabbatar da manufa, Daure, Hoto, Ci gaban Assay

Gudanar da aikace-aikacen guda huɗu a jere. Kowane matakin reagent da buƙatun shaida sun takura na gaba, don haka tsallakewa gaba yawanci yana nufin siyan peptide iri ɗaya sau biyu.

Cascade ba bisa ka'ida ba ne. 'Yan takarar farko da aka yi niyya na SLC ta amfani da kunnawa, daidaitawa da hanyoyin maganin kwayoyin halitta sun riga sun kasance cikin ci gaban asibiti don farfadiya, Autism bakan cuta da kuma na kullum zafi, tare da gwaje-gwajen jiyya na ƙayyadaddun ƙayyadaddun ƙayyadaddun cututtukan neurodevelopmental masu alaƙa da SLC6A1, Ciwon rashi na GLUT1 da cututtukan da ke da alaƙa da SLC13A5 (Drug Target Review, 2026-09-11).

Ci gaban assay yana zama na ƙarshe don dalili: yanayin aikin tantancewa na waɗannan masu jigilar kaya yana da kunkuntar, don haka karatun da za ku iya ginawa ya dogara da abin da matakan farko suka tabbatar.

Zayyana Matsalolin Musamman don Maƙasudin Sufuri

Zane-zane yana farawa daga yankin da kuke buƙatar yin tambayoyi, ba daga kasida ba. Yi yanke shawara da farko ko peptide dole ne ya kwaikwayi ligand mai jigilar kayayyaki na halitta, gasa a sanannen wurin ɗaure, ko Shago kawai ɗaga antibody zuwa madauki. Wannan shawarar ta gyara tsayi, ilimin kimiyya na terminal, da kuma nawa jerin za a iya canza ba tare da rasa hulɗar da kuke son aunawa ba.

Masu jigilar SLC ba sa gafartawa a nan. Tsayin su na transmembrane shine hydrophobic kuma wutsiyoyinsu na cytoplasmic galibi suna da wadatar asali, kuma duka fasalulluka biyu suna yin ƙaƙƙarfan taro mai ƙarfi da tsarkakewa-lokaci mai ƙarfi fiye da ƙayyadaddun furotin mai narkewa.. Yi tsammanin ƙananan yawan amfanin ƙasa, karin tarawa a lokacin cleavage, da kunkuntar taga tsarkakewa. Farashin PHT1 (Saukewa: SLC15A4) daukar ma'aikata na TASL abu ne mai amfani: yana nuna SLC-ligand ganewa da aka warware a matakin kwayoyin, wanda shine matakin daki-daki na jerinku ya mutunta (Sadarwar yanayi, 2023).

Dokoki biyu masu amfani suna bi. Yi oda analog ɗin magana mara lakabi tare da kowane nau'i mai alamar, don haka ana iya auna gudunmawar lakabin maimakon a ɗauka. Kuma ku ɗauki jerin zaɓi azaman rufi akan aikin daga baya: babu darajar tsarkakewa ko inganta aikin tantancewa da ke dawo da mu'amalar da ba a taɓa shigar da tsarin ba.

Fluorescent da Label na Biotin: Zaɓin Binciken Dama

Zaɓi lakabin daga tsarin tantancewa, ba daga abin da jirgi ya fi sauri ba. Takamaiman mai walƙiya sun dace da hoto da ƙayyadaddun ƙirar salula; biotin labels dace dauri, ja-ƙasa da tsarin kama-karya. Samun wannan odar a baya kuma reagent na iya ɓata karatun.

Ya kamata a fayyace bayanin a sarari: fluorophore kanta na iya canza halayen sufuri, don haka peptide mai alamar ba zai zama amintaccen maye ta atomatik ga wanda ba a yiwa lakabin ba (PMC, Hotunan jigilar peptide na warkewa ta hanyar shingen hanji, 2021-06-15). Bi da duk wani canji a cikin bayyananniyar kusanci ko ƙimar ɗauka azaman mallakar haɗin gwiwa har sai kun nuna akasin haka..

Amfanin Biotin shine cewa ya tsaya daga hanyar gani. Hanyar ɗaukar cytometry mai kwarara mai guda ɗaya da aka buga tana ƙididdige fluorescence na peptide a kowane tantanin halitta kuma yana amfani da sodium azide don raba shigar da ke dogaro da makamashi daga ɗaurin sama., sai trypan blue, trypsin ko pronase tsiri don raba na ciki daga peptide mai ɗaure a saman (PMC, cytometry peptide mai gudana ta kwayar halitta guda ɗaya, 2016-12-05). Waɗannan abubuwan sarrafawa sune ke juya lambar haske zuwa da'awar injina, kuma suna aiki ne kawai idan kun san wane gefen membrane na siginar ku ke zaune.

Kasafin kudin lakabin cikin tsarin lokaci da kuma ƙira. N-terminal biotin, biotin-Ahx, Ƙarin FAM da FITC-Ahx suna ɗaukar kusan hukunci na kwana biyu na kasuwanci a kan daidaitattun ƙira. (GenScript na al'ada peptide sabis, shafin sabis na kai tsaye, dawo da 2026-02-12).

Key Takeaway： Daidaita lakabin zuwa tsarin tantancewa da farko, sannan tabbatar da halayen haɗin gwiwa kamar peptide iyaye kafin ku gina ƙarshe akan shi.

Kwanciyar Hankali-Haɓaka Canje-canje da Cinikin Su

gyare-gyaren peptide na inganta kwanciyar hankali yana tsawaita tsawon lokacin da gini ya tsira daga kima, amma irin chemistry ɗin da ke siyan waccan taga zai iya canza yadda peptide ɗin ke ɗaure mai ɗaukarsa sosai. Ɗauki kowane gyare-gyare a matsayin mai canzawa wanda ke buƙatar sarrafa kansa, ba azaman haɓakawa kyauta ba.

Kariyar tasha ta yau da kullun ba ta da wani kari. N-terminal acetylation da C-terminal amidation sune daidaitattun zaɓuɓɓuka, kuma masu samar da kayayyaki yawanci suna ba su ba tare da ƙarin caji ba tare da kasida na fiye da haka 300 gyare-gyaren rukuni-rukuni (GenScript). Katange tasha yana kare kariya daga ɓangarorin exopeptidase, wanda sau da yawa shi ne abu na farko da ke zubar da peptide a cikin jini ko kuma tsawon lokaci.

Kowane fa'ida yana ɗaukar farashi. Maɗaukakin tsarki mafi girma sun dawo da ƙasa da kayan aiki: darajar bincike a 85-95% tsarki ya dawo 40-60% na danyen mai, da ultra-pure material at 98% ko sama ya dawo kawai 20-40% (KeriSite International, dawo da 2026-07-09). Counterion chemistry yana da alaƙa mai alaƙa: trifluoroacetate yana tsayawa da ƙarfi ga N-terminus kyauta da sauran abubuwan da suka rage kamar Arg., Lys, da nasa, da cire shi don nau'in gishiri mai jituwa yana ɗaukar ƙarin matakin musayar ion (Bachem, dawo da 2026-07-28).

Gargadi: Tsararren ginin yana iya canza alaƙar jigilar kaya cikin shiru ko kuma ƙunsar ainihin taga tantancewar da kuka saita don aunawa.. Gudanar da kwatancen da ba a canza shi ba a cikin gwaji iri ɗaya don haka kowane canji yana iya kasancewa ga gyare-gyare maimakon ga peptide kanta..

Gwajin Nazari da QC: Abin da Kunshin Bayananku Dole ne Ya Tabbata

Kashi mai tsabta a kan kansa bai tabbatar da komai ba. Lambar tana zama shaida ne kawai idan ta zo tare da hanyar da ta samar da shi, tantancewa na ainihi wanda ke tabbatar da jerin, da sharuɗɗan karɓan da mai sayarwa ya yi kafin gudu. Tambayi duka ukun, sannan ka nemi danyen bayanan dake bayansu.

Adadin tsarkin da kuke buƙata ya dogara da abin da peptide ya yi. Jagorar Bachem don sarrafa ingancin peptide yana saita ƙofofin fiye da 95% don nazarin hulɗar mai karɓa-ligand da kuma toshewa ko ƙididdigar gasa, 90 ku 95% don aikin ƙididdige enzyme-substrate, da sama 80% don lalatawar Yammacin Turai. Dillali da ke faɗin maki ɗaya ga kowane aikace-aikacen yana gaya muku ba su yi tunanin naku ba.

Identity gwaji ne daban da tsarki. Peptide zai iya zama 98% tsarki kuma har yanzu zama jerin kuskure. Bayanan QC na Wikipept yana karɓar ma'auni a cikin ± 2 Da na ka'idar monoisotopic taro, fadada zuwa ±5 Da a sama 3 kDa, yayin da Farashin ILS yana ba da rahoton ƙarar windows daga LC-MS: ± 0.5 Da akan guda quadrupole guda ɗaya da ± 0.01 Da akan kayan aiki masu ƙarfi. Daidaita haƙuri ga kayan aiki, kuma duba cewa adadin da aka ruwaito shine wanda aka lura, ba darajar ka'idar da aka sake maimaita ba.

Sannan akwai tazara tsakanin tsarki da yawa. Vial mai lakabi 10 MG na iya ɗauka kawai 6 ku 8 MG na ainihin peptide da zarar an ƙidaya counterions da danshi, kamar yadda ILS Labs bayanin kula a cikin siffar QC iri ɗaya. Abin da ya sa abun cikin peptide na yanar gizo ya kasance akan takaddun shaida tare da tsabta, kuma dalilin da yasa jeri-arziki na yau da kullun ke nuna ƙarancin abun ciki daga samuwar gishiri, wani batu Bachem yayi a sarari. Auna maida hankali kan aikinku akan abun cikin yanar gizo, ba nauyi vial, ko kuma duk wani motsin da ke ƙasa ya yi kuskure a hankali.

Endotoxin buƙatun ma'auni tare da binciken. Abun bincike-bincike yawanci ana bayyana su a ƙasa 10 EU/mg, preclinical kasa 1 EU/mg, da na asibiti a kasa 0.25 EU/mg ƙarƙashin iyakokin iyaye na FDA, tare da gwajin LAL akan USP <85> a matsayin hanyar rikodin (wikipept; Farashin ILS). Don gwajin jigilar jigilar tantanin halitta, matakin bincike yawanci ya isa, amma ya kamata a bayyana ƙayyadaddun ba a ɗauka ba.

Cikakken fakitin amfani da bincike don haka yana ɗaukar tsaftar RP-HPLC a UV 214 ko 220 nm akan ginshiƙin C18 tare da acetonitrile/0.1% TFA gradient, Bayanin LC-MS, net peptide abun ciki, LAL endotoxin ta USP <85>, allo mai saurin haihuwa, da karafa masu nauyi ta ICP-MS kowace USP <233> kuma Q3D (Farashin ILS). Najasa a sama 0.5% ya kamata a siffanta maimakon ƙidaya kawai, tare da LC-MS/MS da aka yi amfani da shi don ɗaukar hoto da kuma gano guntu (wikipept).

Gwajin aiki na kunshin bayanai yana da sauƙi: mai bita zai iya sake gina sakamakonku daga gare shi ba tare da tuntuɓar mai kaya ba? Idan chromatogram ba shi da taga haɗin kai, yawan bakan ba shi da kimar gani, ko abun cikin gidan yanar gizon ya ɓace, amsar ita ce a'a.

Matsakaicin Lot-to-Lot da Karatun Takaddar Bincike

Takaddun shaida na bincike iƙirarin mai siyarwa ne game da tsari ɗaya, ba garantin cewa rukuni na gaba zai dace da shi ba. Bi da shi azaman wurin farawa don tabbatarwa, kuma saka haƙƙoƙin da za ku karɓa kafin ku ba da oda.

Rata tsakanin adadi mai tsabta da aka bayyana da wanda aka auna zai iya zama fadi. A 2022 Inter-laboratory binciken gano cewa peptides labeled a 98% ko mafi girma ta hanyar hanya guda ɗaya ta HPLC ta fito daga 94.2% ku 99.1% lokacin da labs guda uku suka sake gudanar da su akan ginshiƙai daban-daban da matakan wayar hannu (KeriSite International, dawo da 2026-07-09). Zaɓin hanya kaɗai yana motsa lambar.

Abubuwan sake nazari masu zaman kansu suna nuni iri ɗaya. A cikin saitin samfuran guda biyar da aka sake gwadawa daga babban rukuni na 30, hudu sun auna fiye da 10% a kasa tsarkin CoA, da samfurin da aka jera a sama 98% dawo a 67%. Wani misali dabam ya nuna a 99.2% CoA wanda abun ciki na peptide da aka yi niyya ya kasance 76% saboda bambance-bambancen 16-mer mai haɗin gwiwa ya haɓaka karatun tsarki (KeriSite International, dawo da 2026-07-09). Kula da tushen: KeriSite mai siyarwa ce mai gasa, kuma waɗannan lokuta masu siyarwa ne suka rubuta, don haka karanta su azaman misali na yanayin gazawar maimakon binciken tsaka tsaki.

Abin da rahoton CoA ya ​​bambanta ta mai siyarwa. Babban ɗakin QC na mai kaya ya haɗa da abun ciki na ruwa ta Karl Fischer titration, abun ciki na nitrogen ta hanyar bincike na asali azaman ma'aunin abun ciki na peptide, ragowar TFA ta ion chromatography, da haɗin kai tare da ma'aunin tunani (Bachem, dawo da 2026-07-28). Idan CoA ɗin ku ya lissafa tsabta da nauyin kwayoyin halitta kawai, kuna rasa filayen da ke bayyana canjin tsakiyar karatu.

Sanya makasudin karɓa a cikin tsari da kanta. Waɗannan su ne juriyar juriya-zuwa-duka wanda ya cancanci ƙididdige su:

Masu ba da kaya da ke aiki don ƙulla maƙasudin ciki suna ba da rahoton tsaftataccen CV a ƙasa 0.5% da CV mai riƙewa a ƙasa 1.0%, tare da ƙimar wucewar ƙayyadaddun gida a sama 95% (KeriSite International, dawo da 2026-07-09). Tambayi mai zuwa ga bayanan CV ɗin su mai yawa, ba kawai CoA-batch guda ɗaya ba. Matsakaicin yawa-zuwa-yawa shine da'awar tsari, kuma kawai shaidarsa ita ce rarraba a cikin batches.

Bambance-bambancen gama gari Game da Reagents na Peptide a Aikin Sufuri

Mafi tsada kuskure a cikin aikin sufuri shine cewa babban adadin tsabta yana nufin ingantaccen reagent. Tsafta dukiya daya ce a tsakanin da yawa, da kuma tunanin da ke lalata peptide a hankali yakan zauna a waje da adadi gaba ɗaya.

Alamun peptide yana musanya tare da analog ɗin sa mara lakabi. Ba haka ba ne. Ƙara fluorophore ko biotin yana canza nauyin kwayoyin halitta, hydrophobicity, kuma sau da yawa transporter dangantaka, don haka bincike mai lakabi yana buƙatar halayen ɗaurin kansa maimakon gaji lambobin peptide mara alamar.. Samuwar Peptide

Siffar tsarkin shedar-bincike tana canjawa cikin hanyoyin nazari. Bai yi ba. Ƙimar da aka samu ta hanyar HPLC ɗaya ba ta kamanta da ƙima daga wani nau'in gradient daban, shafi, ko tsinkayar zango, don haka kwatanta adadi kawai lokacin da hanyar ta dace.

Ana yin watsi da abun cikin peptide na yanar gizo lokacin da ake ƙididdige ƙididdigewa. Abubuwan da ke cikin peptide na yanar gizo suna canza kowane lissafin molarity. Yin auna kayan ta babban taro da kuma bi da shi azaman peptide mai tsafta yana nuna adadin reagent mai aiki a cikin bututu., wani lokacin ta gefe mai fadi.

TFA-gishiri abu yana tafiya kai tsaye zuwa cikin gwaje-gwajen tantanin halitta. Ƙididdigar tantanin halitta tana shafar ƙima, kuma darajar da aka jera don waɗannan ƙididdigar shine ≥98% abun ciki peptide da aka kawo azaman TFA ko gishiri acetate. (KeriSite International, 2026-07-09). Inda kishiyar kanta ke damun karatun, tabbatar da nau'in gishiri kafin aunawa, ba bayan.

Key Takeaway: Kuskuren mafi tsada ba ƙaramin tsarki bane. Reagent ne wanda ya wuce kowane takamaiman bayani yayin da yake hutawa kan zato mara kyau game da lakabi, hanya, molarity, ko gishiri siffan.

Misalin Aiki: Gina ɗaya Ta hanyar Cascade

Tawagar masu jigilar kaya da ta fara daga sananniya mai ɗorewa suna tsara peptides guda uku a layi daya: analog na magana mara lakabi, bincike mai alamar haske, da kuma reagent kama biotinylated. Analogin tunani yana saita tushe. Ba tare da shi ba, Sauya sigina daga alamar bincike ba za a iya dangana ga lakabin maimakon jerin kansa ba..

Zane jeri yana farawa tare da abubuwan tantancewa da aka san manufa da amfani, tun da yadda za a iya warware peptide fitarwa ta SLC ta hanyar tsari ya dogara da adana waɗannan lambobin sadarwa. Sifukan da aka yi wa lakabi da biotinylated sannan suna ɗaukar jerin asali iri ɗaya, tare da gyare-gyaren da aka sanya a tasha ko wurin da aka fallasa da ƙarfi maimakon a cikin fuskar ɗaure.

A cikin assay handoff, Gudanar da azide da cirewa sun tabbatar da cewa siginar tana nuna takamaiman ɗauri maimakon tallan da ba na musamman ba.. QC yana ƙofofin ginin kafin ya isa wancan matakin: matrix mai tsabta ta aikace-aikacen yana tabbatar da peptide yana yin aiki a cikin buffer da aka yi niyya da yanayin ganowa, da net peptide abun ciki, ba babban nauyi ba, yana saita molarity da aka yi amfani da shi a cikin lissafin dauri.

Iyakoki da Lokacin da Peptides sune Kayan aiki mara kyau

Peptides kayan aikin da ba daidai ba ne lokacin da shirin yana buƙatar karantawa na sufuri mai aiki wanda bai wanzu ba tukuna. Filin jigilar kaya yana da kunkuntar shimfidar wuri mai aiki, don haka peptide reagent zai iya ba da ɗauri, localization ko bayanan alaƙa, amma ba zai iya tsayawa ba don auna jigilar da kanta. Idan tambaya ita ce ko substrate yana motsawa a kan membrane, binciken peptide ya amsa wata tambaya daban.

Makanikan samun dama-dama suna sanya iyaka ta biyu. Domin waɗannan sunadaran suna zagayawa tsakanin ciki- da abubuwan da suke fuskantar waje, gwaje-gwajen sukan kama jihar guda a lokaci guda, kuma peptide da aka inganta akan wata jiha bazai bayar da rahoto akan ɗayan ba. Lakabin rikicewa ya haɗa wannan: haɗa fluorophore ko biotin na iya ɓata ma'aunin ɗaurin kai tsaye, da gyare-gyaren haɓaka natsuwa na iya canza alaƙar da ta isa ta yadda ingantaccen ginin ba zai zama mai kwatanta kai tsaye ba akan jerin iyaye..

Ɗauki kowane ɗayan waɗannan a matsayin dalilin isa ga ilimin halitta, ingantaccen fili kayan aiki ko tantancewar orthogonal maimakon. Over-da'awar abin da reagent aji na iya tabbatar da tsadar shirin kwata.

Farawa: Matakai na Farko don Aikin Jirgin Peptide

Ƙayyade ƙididdiga da reagent zai yi aiki kafin ku nemi wani abu. Sharuɗɗan karɓa suna zuwa na farko: darajar tsarki, net peptide abun ciki, gishiri siffan, juriya-zuwa-tsari, da hanyoyin nazarin da za su nuna kowannensu. Kalmomin da ake nema kafin waɗannan ƙayyadaddun bayanai yakan dawo tare da zato ba ku zaɓa ba.

Matakai uku suna cire yawancin gogayya:

1. Rubuta sharuɗɗan karɓa, sa'an nan nemi da zance. Fadi tsarin tantancewa, buffer, aiki maida hankali, da juriya da za ku yarda tsakanin kuri'a.

2. Yi oda analog ɗin magana mara lakabi tare da ginin da aka yi wa lakabin. Yana ba ku iko don lakabin kanta da hanyar tabbatar da cewa duk wani canjin sigina ya fito daga gyare-gyare, ba da peptide.

3. Nemi cikakken kunshin nazari, ba adadi mai tsarki ba. HPLC, Mass spectrometry, da takardar shaidar bincike ya baka damar tabbatar da ainihi da kuma tsabta.

Tsara lokaci a kusa da sunadarai. Daidaitaccen haɗin al'ada yana gudana game da 2 ku 3 makonni, gyare-gyaren jeri 4 ku 6 makonni, da conjugation 3 ku 5 makonni (Tsingke peptide kira ayyuka, dawo da 2026-08-21). Idan an kayyade ranar tantancewar ku, fara da ginin da aka gyara.

Idan kuna son ra'ayi na biyu akan ko burin ku da abin karantawa sun dace kafin aiwatar da jeri, yi magana da ƙwararre ko buƙatar tantance yuwuwar. Canjin MOL yana ba da sabis na peptide na al'ada, don haka ɗaukar wannan a matsayin sha'awar kasuwanci yayin auna shawarar da ke sama.

Tambayoyin da ake yawan yi

Wane irin tsarki nake buƙata don gwajin ɗaurin jigilar jigilar kaya?

Sama 95% shine bakin aiki don hulɗar mai karɓa-ligand da toshewa ko ƙididdigar gasa, ta Bachem's peptide tsarki jagora. Tsafta kadai baya sanya reagent dacewa don amfani: Haɗa shi tare da tabbatarwa na ainihi da adadi na abun ciki na peptide kafin ƙididdige ƙididdiga.

Tambarin mai kyalli na iya canza yadda peptide na ke hulɗa da mai jigilar kaya?

Ee. Fluorophore kanta na iya canza halayen sufuri, kamar yadda aka ruwaito a cikin a 2021 nazarin analogues substrate mai kyalli. Gudanar da kwatancen mara lakabi a cikin kima guda don ku iya raba tasirin alamar daga tasirin jeri.

Ta yaya zan tabbatar da ainihin peptide ba wai kawai tsarkinsa ba?

Tabbatar da taro. Adadin da aka auna yakamata ya faɗi tsakanin ± 2 Da na ka'idar monoisotopic taro ta ESI-MS ko MALDI-TOF, ƙarfafawa zuwa ± 0.5 Da ta guda-quad LC-MS da ± 0.01 Da ta babban ƙuduri MS, bisa ga ƙayyadaddun ƙididdiga na Laboratories na ILS. Alamar tsafta ba tare da tarin bakan ba ya gaya muku komai game da ko an yi daidaitaccen jeri.

Menene ma'anar abun ciki na peptide kuma me yasa yake da mahimmanci?

Abubuwan da ke cikin peptide na yanar gizo shine adadin ainihin peptide a cikin vial da zarar an ƙididdige adadin ruwa da sauran ruwa., kuma yana iya zama da kyau a ƙasa da adadi mai tsabta. ILS Laboratories sun lura cewa 10 MG na lyophilized foda zai iya ƙunsar kawai 6 ku 8 MG na peptide, wanda ke canza kowane lissafin molarity a ƙasa.

Shin zan nemi TFA ko gishirin acetate?

Ya dogara da kimantawa. Trifluoroacetate yana ɗaure da ƙarfi ga N-terminus kyauta da sarƙoƙin gefe na asali kuma ba za a iya cire shi gaba ɗaya ba., don haka aikin tushen tantanin halitta mai jujjuyawa yana kira ga gishiri mai dacewa da ion, kamar yadda Bachem da KeriSite duka suka bayyana. Gwaje-gwajen dauri a cikin buffer yawanci suna jure wa TFA; kididdigar safarar tantanin halitta ba sau da yawa ba.

Nawa bambancin-zuwa-yawa zan yi tsammanin tsakanin batches peptide?

Fiye da yawancin masu bincike suna zato. Peptides mai lakabi a 98% ko mafi girma ta hanyar hanya guda ɗaya ta HPLC ta fito daga 94.2% ku 99.1% fadin dakunan gwaje-gwaje uku a cikin a 2022 kwatanta tsakanin dakin gwaje-gwaje da aka buga a cikin Amino Acids. Ƙayyade juriya-zuwa-tsalle a cikin tsari: lokacin riƙewa a cikin ± 0.2 min, tsabta a cikin ± 0.5% yanki, abun ciki na peptide a cikin ± 5%.

Ina shirye-shiryen jigilar SLC ke tafiya na gaba?

Zuwa ga tsarin tantancewa waɗanda ke karanta aikin jigilar kaya a cikin tsarin rayuwa maimakon a keɓance shirye-shiryen membrane, wanda ke ɗaga mashaya don ƙirar bincike. peptides da aka yi wa lakabi da haske don hoton jigilar kayayyaki da peptides na biotinylated don nazarin ɗaurin jigilar jigilar kayayyaki ana ƙara ƙayyadad da su tare a cikin aikin guda ɗaya ta yadda jeri ɗaya ya yi hidimar karantawa duka biyun..

Kammalawa

Reagent yana da kyau kawai kamar shaidar nazarin da ke bayansa, kuma odar cascade ta yanke shawarar wacce shaidar da kuke buƙata ta farko. Peptide na al'ada don binciken jigilar jigilar SLC yana samun matsayinsa a cikin aikin lokacin da jerin ya dace da manufa, lakabin ba ya gurbata ilimin halitta da kuke aunawa, duk wani gyare-gyaren kwanciyar hankali ya dace da cinikin sa, kuma kunshin bayanan yana tabbatar da ainihi, tsarki, da net abun ciki maimakon tabbatar da su. Yi kuskuren odar kuma ku biya shi daga baya, wanda shine daidai inda sauye-sauye-da yawa da aka gani a sake nazari mai zaman kansa ya zama tsada.

Filin bai tsaya cak ba. Shirye-shiryen SLC masu tasowa a yanzu a cikin ci gaban asibiti suna matsawa zuwa ga kunnawa da hanyoyin maganin kwayoyin halitta, don haka buƙatun reagent da kuka rubuta cikin takamaiman bayani a yau za su ci gaba da canzawa. Gina al'ada a yanzu: ayyana gwajin farko, sai bincike, sannan ka'idojin karba na nazari. Matakan farko a cikin Farawa sune waɗanda za ku koma cikin ƙungiyar ku a wannan makon.